SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
75 hedge funds and large institutions have $112M invested in Syros Pharmaceuticals, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
+17
Holders Change %
+29.31%
% of All Funds
1.09%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
22
Increased
21
Reduced
7
Closed
5
Calls
$162K
Puts
$3K
Net Calls
+$159K
Net Calls Change
-$516K
Top Buyers
| 1 |
OM
1
Opaleye Management
Boston,
Massachusetts
|
$4.21M |
| 2 |
KCM
2
Kennedy Capital Management
St Louis,
Missouri
|
$2.17M |
| 3 |
3
Walleye Capital
New York
|
$1.52M |
| 4 |
4
Millennium Management
New York
|
$1.4M |
| 5 |
5
Goldman Sachs
New York
|
$2.39M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TCM
76
Tang Capital Management
San Diego,
California
| – | -$662K | -85,031 | Closed |
|
|
EI
77
EAM Investors
Solana Beach,
California
| – | -$654K | -84,002 | Closed |
|
|
6CM
78
683 Capital Management
New York
| – | -$284K | -36,444 | Closed |
|
79
Citadel Advisors
Miami,
Florida
| – | -$48.1K | -6,180 | Closed |
|
80
Group One Trading
Chicago,
Illinois
| – | -$9.96K | -1,279 | Closed |
|